Research indicates that cannabis use causes cellular damage that increases the risk of highly cancerous tumors by disrupting ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

A 'deep learning' artificial intelligence model can identify pathology, or signs of disease, in images of animal and human tissue much faster, and often more accurately, than people. The development ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces financial results and a business update for the third quarter of 2024. Volition management ...

A deep learning artificial intelligence model developed at Washington State University can identify pathology, or signs of ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

Tune Therapeutics Moves into Clinical Spotlight with TUNE-401: A First-in-Class Epigenetic Silencer for Hepatitis B ...

According to Fast Company Executive Board member Pelin Thorogood, consumers are searching beyond one-size-fits-all models, ...

The deal between the two is set to advance the company’s blood test before rolling it out across more indications.